Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International journal of pharmaceutics

• Publication date

  2005-09-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJPHARM.2005.05.028PMID 16023313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles

  2005cited by this paper
• Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.

  2004cited by this paper
• Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles1

  2004cited by this paper
• Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1

  2004cited by this paper
• Enhancing Immunogenicity and Reducing Dose of Microparticulated Synthetic Vaccines: Single Intradermal Administration

  2004cited by this paper
• Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.

  2004cited by this paper
• An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria.

  2003cited by this paper
• Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells

  2003cited by this paper
• Potentiation of Immune Response from Polymer-Entrapped Antigen: Toward Development of Single Dose Tetanus Toxoid Vaccine

  2003cited by this paper
• Microencapsulation of vaccine antigens.

  2003cited by this paper
• Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.

  2002cited by this paper
• Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.

  2002cited by this paper
• On Technological and Immunological Benefits of Multivalent Single-Injection Microsphere Vaccines

  2002influential reference
• Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.

  2002cited by this paper
• Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.

  2002cited by this paper
• Size-Dependency of DL-Lactide/Glycolide Copolymer Particulates for Intra-Articular Delivery System on Phagocytosis in Rat Synovium

  2002cited by this paper
• Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres.

  2002cited by this paper
• Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery

  2002cited by this paper
• Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

  2002cited by this paper
• Formulation and Characterization of Immunoreactive Tetanus Toxoid Biodegradable Polymer Particles

  2001cited by this paper
• Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

  2001cited by this paper
• Tetanus toxoid loaded 'preformed microspheres' of cross-linked dextran.

  2001cited by this paper
• Ambiguities in the preclinical quality assessment of microparticulate vaccines.

  2000cited by this paper
• Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles

  2000cited by this paper
• Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.

  2000cited by this paper
• Biodegradable microspheres containing influenza A vaccine: immune response in mice.

  1999cited by this paper
• Single-administration vaccines: controlled-release technology to mimic repeated immunizations.

  1999influential reference
• Fully mobilizing host defense: Building better vaccines

  1998cited by this paper
• Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

  1998cited by this paper
• Stabilization of dichloromethane-induced protein denaturation during microencapsulation.

  1998cited by this paper
• Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

  1998cited by this paper
• Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.

  1998cited by this paper
• Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.

  1997influential reference
• New advances in microsphere-based single-dose vaccines.

  1997cited by this paper
• Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

  1997cited by this paper
• Analysis of MHC class II presentation of particulate antigens of B lymphocytes.

  1996cited by this paper
• Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.

  1996cited by this paper
• Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

  1996cited by this paper
• Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.

  1996cited by this paper
• Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.

  1996cited by this paper
• Size effect on the antibody production induced by biodegradable microspheres containing antigen.

  1996cited by this paper
• Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.

  1994cited by this paper
• Dose and Load Studies for Subcutaneous and Oral Delivery of Poly(lactide-co-glycolide) Microspheres Containing Ovalbumin

  1994cited by this paper
• Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.

  1993cited by this paper
• The synovial response to intraarticular injection in rats of polyethylene wear particles.

  1993cited by this paper
• Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.

  1992cited by this paper
• Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.

  1988cited by this paper
• The stabilization of proteins by sucrose.

  1981influential reference

• Design and applications of immunomodulatory microspheres: From material properties to multisystem disease therapies

  2026cites this paper
• Large Clostridial Toxins: A Brief Review and Insights into Antigen Design for Veterinary Vaccine Development

  2024cites this paper
• Design Principles for Immunomodulatory Biomaterials.

  2024cites this paper
• The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants

  2023cites this paper
• Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants

  2022cites this paper
• 5th INTERNATIONAL SYMPOSIUM ON BACTERIAL CELLULOSE

  2022cites this paper
• Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer

  2022cites this paper
• Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro

  2022cites this paper
• Microparticles entrapping pneumococcal protein SP0845 show improved immunogenicity and temperature stability.

  2022cites this paper
• Production and Functional Evaluation of Anti-Loxosceles Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D

  2022cites this paper
• Impact of lipid nanoparticle size on mRNA vaccine immunogenicity.

  2021cites this paper
• Synthesis and Characterization of Click Nucleic Acid Conjugated Polymeric Microparticles for DNA Delivery Applications.

  2021cites this paper
• Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

  2021cites this paper
• Cellular uptake of polylactide particles induces size dependent cytoskeletal remodeling in antigen presenting cells.

  2021cites this paper
• Continuous High‐Throughput Fabrication of Architected Micromaterials via In‐Air Photopolymerization

  2020cites this paper
• Mucosal Delivery of Drugs and Biologics in Nanoparticles

  2020cites this paper
• Nanoparticle Vaccines for Immunotherapy: From Design to Clinical Trials

  2020cites this paper
• Technological Approaches for Improving Vaccination Compliance and Coverage

  2020cites this paper
• Effect of N-terminal poly histidine-tag on immunogenicity of Streptococcus pneumoniae surface protein SP0845.

  2020cites this paper
• Poly(lactic acid) microcapsules: Tailoring properties via solid state polymerization

  2020cites this paper
• Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases

  2020cites this paper
• Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases

  2020cites this paper
• Immunogenicity and contraceptive efficacy of recombinant fusion protein encompassing Sp17 spermatozoa‐specific protein and GnRH: Relevance of adjuvants and microparticles based delivery to minimize number of injections

  2019cites this paper
• Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines

  2019cites this paper
• Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles

  2019cites this paper
• Innovative antigen carrier system for the development of tuberculosis vaccines

  2019cites this paper
• Using Montanide TM ISA 50 V 2 as adjuvant for the formulation of the anti-tick Gavac ® vaccine

  2018cites this paper
• Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

  2018cites this paper
• Investigating biomaterial-based biophysical cues for modulating macrophage polarization towards bone regeneration applications

  2018cites this paper
• Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection

  2018cites this paper
• Biodegradable Polymeric Nanocarrier-Based Immunotherapy in Hepatitis Vaccination.

  2018cites this paper
• A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses.

  2018cites this paper
• Size regulates particulate adjuvant induced IL-10 and IL-12p70 production

  2018cites this paper
• Microfluidic production of degradable thermoresponsive poly(N-isopropylacrylamide)-based microgels.

  2017cites this paper
• Vaccine Adjuvants

  2017cites this paper
• Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines.

  2017cites this paper
• Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

  2017cites this paper
• Fabrication of polymeric microcarriers with reduced permeability using layer-by-layer, surface-initiated polymerization and emulsion techniques

  2017cites this paper
• Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model

  2017cites this paper
• Antibody Response is Differentially Influenced by PLGA-PAD4 Particle Characteristics

  2017cites this paper
• Optimisation de l'activité immunostimulatrice des lymphocytes T Natural Killer invariants : conséquences sur l'immunité anti-tumorale

  2017cites this paper
• Converting Red Blood Cells to Efficient Microreactors for Blood Detoxification

  2017cites this paper
• Adjuvants in micro- to nanoscale: current state and future direction.

  2016cites this paper
• PLGA particulate delivery systems for subunit vaccines : Linking particle properties to immunogenicity

  2016cites this paper
• Modulation of Immune Responses by Particulate Materials

  2016cites this paper
• PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

  2016cites this paper
• Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines.

  2016cites this paper
• Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure

  2016cites this paper
• Development of monoclonal antibody and lateral test strip for sensitive detection of clenbuterol and related β2-agonists in urine samples

  2016cites this paper
• Investigation into Self-Assembling Microcrystals as an alternative to polysaccharide-based conjugate vaccines

  2016cites this paper
• Production of functional pharmaceutical nano/micro-particles by solvent displacement method using advanced micro-engineered dispersion devices

  2016cites this paper
• Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens.

  2015cites this paper
• Vaccine adjuvant uses of poly-IC and derivatives

  2015cites this paper
• Shape and size-dependent immune response to antigen-carrying nanoparticles.

  2015cites this paper
• Role of polymer–drug conjugates in organ-specific delivery systems

  2015cites this paper
• Adjuvanted trimethyl chitosan based nanoparticle formulations to improve immunogenicity of DNA vaccines

  2015cites this paper
• Particle size and traffic of phagocytes between the turbot peritoneal cavity and lymphoid organs.

  2015cites this paper
• Formulations de vaccin particulaire pour induire l'immunité innée et acquise

  2015cites this paper
• PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma

  2015cites this paper
• PLGA-based particulate vaccine delivery systems for immunotherapy of cancer

  2015cites this paper
• Development of Pasteurella multocida-loaded microparticles for hemorrhagic septicemia vaccine

  2015cites this paper
• Uniform-sized particles in biomedical field prepared by membrane emulsification technique

  2015cites this paper
• A Review of Intra- and Extracellular Antigen Delivery Systems for Virus Vaccines of Finfish

  2015cites this paper
• Hydrochlorothiazide containing PLGA nanoparticles: Design, characterization, in-vitro drug release and release kinetic study

  2015cites this paper
• In situ polyethylene sebacate particulate carriers as an alternative to Freund's adjuvant for delivery of a contraceptive peptide vaccine--A feasibility study.

  2015cites this paper
• CpG-carrier size and density affects dendritic cell signaling, subset-tropism and systemic immune polarization

  2015cites this paper
• Particles from preformed polymers as carriers for drug delivery

  2014cites this paper
• Fusion and self-assembly of biodegradable polymer particles into scaffoldlike and membranelike structures at room temperature for regenerative medicine.

  2014cites this paper
• A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.

  2014cites this paper
• A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.

  2014cites this paper
• Entrapment in plasma microparticles: a promising strategy for antigen delivery.

  2014cites this paper
• Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.

  2014cites this paper
• Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery.

  2014cites this paper
• Surface charge of PLA microparticles in regulation of antigen loading, macrophage phagocytosis and activation, and immune effects in vitro

  2014cites this paper
• Delivery of polysaccharides using polymer particles: implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity.

  2014cites this paper
• Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A.

  2014cites this paper
• Vaccine Delivery Systems for Veterinary Immunization

  2014cites this paper
• Re-considering how particle size and other properties of antigen-adjuvant complexes impact on the immune responses.

  2013cites this paper
• Development and Evaluation of Chitosan Particle Based Antigen Delivery Systems for Enhanced Antigen Specific Immune Response

  2013cites this paper
• Nanoparticles and microparticles of polymers and polysaccharides to administer fish vaccines.

  2013cites this paper
• Status and future perspectives of vaccines for industrialised fin-fish farming.

  2013cites this paper
• Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective

  2013cites this paper
• Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity.

  2013cites this paper
• Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses

  2013cites this paper
• On designing particulate carriers for encapsulation and controlled release applications

  2013cites this paper
• Transcutaneous immunization using lipid colloidal systems and microneedles

  2013cites this paper
• Microspheres and Microcapsules for Protein Drug Delivery

  2013cites this paper
• Role Of Polymeric Excipients On Controlled Release Profile of Glipizide from PLGA and Eudragit RS 100 Nanoparticles

  2013cites this paper
• Effect of a nano-sized natural clinoptilolite modified by the hexadecyltrimethyl ammonium surfactant on cephalexin drug delivery

  2013cites this paper
• Paclitaxel loaded poly- d , l -lactide-co-glycolide nanoparticles: Enhanced anticancer effect in non-small cell lung carcinoma cell line

  2013cites this paper
• Biocompatibility and cytotoxic evaluation of drug-loaded biodegradable guided tissue regeneration membranes

  2012cites this paper
• PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).

  2012cites this paper
• PLGA and PLA particles as vaccine delivery systems for Atlantic salmon : a study on formulation and use with an emphasis on immune responses

  2012influential citation
• Ferulic acid loaded Poly-d,l-lactide-co-glycolide nanoparticles: Systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small cell lung carcinoma cell line in vitro

  2012cites this paper
• Polyclonal antibodies in livestock for treatment of ingested toxin in human

  2012cites this paper
• Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.

  2012cites this paper
• Nanotechnology in Vaccine Development

  2012cites this paper
• The immunogenic characteristics associated with multivalent display of Vi polysaccharide antigen using biodegradable polymer particles.

  2012cites this paper
• Physical and Chemical Strategies for Therapeutic Delivery by Using Polymeric Nanoparticles

  2012cites this paper
• Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.

  2012cites this paper